[1]
2025. Comparative Assessment Of Health-Related Quality Of Life In Osteoporosis Patients Treated With Teriparatide Versus Zoledronic Acid: A Prospective, Observational Study Using The OPAQ-SV Questionnaire. International Journal of Environmental Sciences. (Jul. 2025), 1063–1068. DOI:https://doi.org/10.64252/zgx5f476.